• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$41.23 $0.05 (0.12%)

REAL-TIME: Last trade at

AstraZeneca plc (ADR)

NYSE:AZN

Jump to this page for:

Related Resources

Data Presented at the European Atherosclerosis Society Congress Reinforces the Differentiating Benefits of CRESTOR[TM] in Comparison to Atorvastatin and Simvastatin

5/28/2012 by PR Newswire

Innovative public-private collaboration launches to tackle antibiotic research

5/25/2012 by PharmiWeb.com - UK

GlaxoSmithKline and AstraZeneca invest in antibiotic research

5/24/2012 by Guardian Unlimited - UK

BT chief rings up £7.7m in cash-and-shares pay

5/24/2012 by FT.com

Drug Giants Such as AstraZeneca PLC, GlaxoSmithKline, Sanofi (France) Join Forces With Academia on $285 Million Antibiotic Pact

5/24/2012 by BioSpace

Recycler Jayplas to take over old AstraZeneca site

5/24/2012 by Waste News

Pharmaceuticals - Global Group of Eight (G8) Industry Guide

5/23/2012 by PR Newswire

Global pharma

5/22/2012 by FT.com

FTSE 100 rises on eurobond hopes

5/22/2012 by FT.com

Docs slower to drop 'black box' drugs, adopt new therapies, when access to drug reps is restricted, reports Journal of Clinical Hypertension

5/21/2012 by PR Newswire

AstraZeneca Eyes Collaborations, M&As, Private Investors to Boost Pipeline

5/21/2012 by Genetic Engineering News

Anesthesia Drugs Market (2011 - 2015) - U.S. Market Entry Study

5/21/2012 by PR Newswire

R&D Trends 2012 - Pharmaceutical Companies use Externalization & Collaboration to Drive Growth

5/21/2012 by PR Newswire

Birmingham bids for clinical drug trials

5/20/2012 by FT.com

AstraZeneca looks to revive experimental drugs

5/20/2012 by FT.com

Investor anger hits Cairn, Pru and Cookson

5/17/2012 by FT.com

Astrazeneca Pharma, Dish TV, Indoco witness abnormal volume

5/17/2012 by Myiris - India

Leadership transition upcoming at AstraZeneca

5/16/2012 by Chain Drug Review

Wednesday newspaper round-up: Greece, RBS, AstraZeneca

5/16/2012 by London Stock Exchange - UK

Amylin Said to Attract Interest From Pfizer, AstraZeneca

5/15/2012 by Drug Topics

Pipelines Under Pressure Take New Paths

5/15/2012 by Drug Discovery & Development

First wave of AstraZeneca's CNS R&D group gets the ax

5/15/2012 by Fierce Biotech

Yield, Value, Safety: Are They Still Available For Big Pharma? (Part 2)

5/14/2012 by Seeking Alpha

4 Big Pharma Stocks To Nab In A Pullback

5/14/2012 by Seeking Alpha

Why Johnson & Johnson Looks Better Than Its Competitors

5/13/2012 by Seeking Alpha

Sanofi Could Plummet On Imminent Plant Shutdown

5/11/2012 by Seeking Alpha

Promising USF drug falls short in trials

5/11/2012 by TBO.com - Tampa Bay FL

AstraZeneca Is Undervalued

5/10/2012 by Seeking Alpha

AstraZeneca (AZN) Says SYMBICORT Shows Similar Safety Profile to Budesonide in Certain Asthma Patient Groups

5/10/2012 by StreetInsider.com

Tang Capital's Holdings: Insights Into Successful Investing

5/7/2012 by Seeking Alpha

3 'Big Pharma' Stocks To Consider Now

5/7/2012 by Seeking Alpha

3 Overvalued Pharmaceutical Stocks That May Tumble By 2013

5/3/2012 by Seeking Alpha

GlaxoSmithKline not interested in buying AstraZeneca

5/3/2012 by Triangle Business Journal - Raleigh NC

AstraZeneca officially terminates TC-5214 licensing agreement with Targacept

4/30/2012 by Winston-Salem Journal - Winston-Salem NC

CEO of Targacept partner AstraZeneca resigns

4/27/2012 by The Business Journal - Greensboro NC

AstraZeneca CEO stepping down

4/26/2012 by The Philadelphia Inquirer - Philadelphia PA

AstraZeneca CEO to step down as Q1 profit plunges

4/26/2012 by The Boston Globe - Boston MA

AstraZeneca CEO stepping down

4/26/2012 by Philadelphia Business Journal - Philadelphia PA

SAN DIEGO’S ARDEA SOLD TO GIANT DRUGMAKER FOR ...

4/24/2012 by The San Diego Union Tribune - San Diego CA